These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Oral prostacyclin therapy for pulmonary arterial hypertension: another step forward. Waxman AB Circulation; 2013 Feb; 127(5):563-5. PubMed ID: 23307828 [No Abstract] [Full Text] [Related]
6. Safety and Tolerability of High-dose Inhaled Treprostinil in Pulmonary Hypertension. Parikh KS; Rajagopal S; Fortin T; Tapson VF; Poms AD J Cardiovasc Pharmacol; 2016 Apr; 67(4):322-5. PubMed ID: 26828324 [TBL] [Abstract][Full Text] [Related]
7. [Role of prostacyclin and its derivatives in the treatment of pulmonary arterial hypertension]. Osvaldo Cáneva J; Ossés JM Medicina (B Aires); 2003; 63(3):233-6. PubMed ID: 12876911 [TBL] [Abstract][Full Text] [Related]
8. Transition from intravenous or subcutaneous prostacyclin therapy to inhaled treprostinil in patients with pulmonary arterial hypertension: a retrospective case series. Enderby CY; Soukup M; Al Omari M; Zeiger T; Burger C J Clin Pharm Ther; 2014 Oct; 39(5):496-500. PubMed ID: 24806480 [TBL] [Abstract][Full Text] [Related]
9. Transition From Subcutaneous or Inhaled Treprostinil to Oral Treprostinil at Home in Patients With Pulmonary Arterial Hypertension: A Retrospective Case Series. Ackerbauer KA; Tandon R J Pharm Pract; 2018 Apr; 31(2):163-166. PubMed ID: 28464760 [TBL] [Abstract][Full Text] [Related]
10. Transition from epoprostenol and treprostinil to the oral endothelin receptor antagonist bosentan in patients with pulmonary hypertension. Suleman N; Frost AE Chest; 2004 Sep; 126(3):808-15. PubMed ID: 15364760 [TBL] [Abstract][Full Text] [Related]
11. Parenteral and inhaled prostanoid therapy in the treatment of pulmonary arterial hypertension. McLaughlin VV; Palevsky HI Clin Chest Med; 2013 Dec; 34(4):825-40. PubMed ID: 24267307 [TBL] [Abstract][Full Text] [Related]
13. Oral treprostinil for the treatment of pulmonary arterial hypertension. de Lartigue J Drugs Today (Barc); 2014 Aug; 50(8):557-65. PubMed ID: 25187906 [TBL] [Abstract][Full Text] [Related]
14. [Prostacyclin and iloprost in aerosol form in severe pulmonary hypertension]. Olschewski H; Walmrath D; Schermuly R; Ghofrani HA; Grimminger F; Seeger W Pneumologie; 1998 Jan; 52(1):3-7. PubMed ID: 9540363 [No Abstract] [Full Text] [Related]
15. Inhaled treprostinil for the treatment of pulmonary arterial hypertension. LeVarge BL; Channick RN Expert Rev Respir Med; 2012 Jun; 6(3):255-65. PubMed ID: 22788940 [TBL] [Abstract][Full Text] [Related]
16. Transition from IV epoprostenol to subcutaneous treprostinil in pulmonary arterial hypertension: a controlled trial. Rubenfire M; McLaughlin VV; Allen RP; Elliott G; Park MH; Wade M; Schilz R Chest; 2007 Sep; 132(3):757-63. PubMed ID: 17400684 [TBL] [Abstract][Full Text] [Related]
17. Efficacy of long-term subcutaneous treprostinil sodium therapy in pulmonary hypertension. Lang I; Gomez-Sanchez M; Kneussl M; Naeije R; Escribano P; Skoro-Sajer N; Vachiery JL Chest; 2006 Jun; 129(6):1636-43. PubMed ID: 16778286 [TBL] [Abstract][Full Text] [Related]
18. Infections by gram-negative bacilli in patients with pulmonary arterial hypertension treated with intravenous prostacyclin. Gómez Sánchez MA Arch Bronconeumol; 2013 Mar; 49(3):128-9. PubMed ID: 23127721 [No Abstract] [Full Text] [Related]
19. Conversion to bosentan from prostacyclin infusion therapy in pulmonary arterial hypertension: a pilot study. Steiner MK; Preston IR; Klinger JR; Criner GJ; Waxman AB; Farber HW; Hill NS Chest; 2006 Nov; 130(5):1471-80. PubMed ID: 17099026 [TBL] [Abstract][Full Text] [Related]
20. Combining treprostinil and sildenafil in the treatment of pulmonary hypertension. Chua R; Keogh A Intern Med J; 2005 Nov; 35(11):684-5. PubMed ID: 16248867 [No Abstract] [Full Text] [Related] [Next] [New Search]